Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of Gemcitabine with Paclitaxel versus Standard Chemotherapy Combination for Patients with Borderline Resectable Pancreatic Cancer Based on Gene Analysis

    Recruiting

    2 1 1 1
    France
  • Study of XELOX chemotherapy with or without dostarlimab after chemoradiation in patients with locally advanced rectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Study of Izalontamab Brengitecan Compared to Standard Chemotherapy in Untreated Triple-negative or ER-low, HER2-negative Breast Cancer Patients Not Eligible for Anti-PD1/PD-L1 Treatment

    Recruiting

    4 1 1 1
    Austria France Germany Greece Italy Poland +4
  • Study of IMVT-1402 in Adults with Mild to Severe Generalized Myasthenia Gravis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia Denmark Germany Greece Hungary Italy +3
  • Comparison of Pregabalin and Baclofen Treatment in Patients with Spastic Motor Behavior Following Cervical or Thoracic Spinal Cord Injury

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • Study of Trastuzumab Deruxtecan Blood Levels in Normal Weight and Overweight Patients with Metastatic Breast Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of inhaled corticosteroids (beclometasone, fluticasone, budesonide) and salbutamol in children aged 1-6 years with episodic wheezing

    Recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study of Ropivacaine for Pain Control in Patients Having Open Heart Surgery Through Chest Bone Incision

    Recruiting

    3 1 1
    Belgium
  • Study of toripalimab, cisplatin and gemcitabine combination as first treatment for patients with recurrent or metastatic nasopharyngeal cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Study comparing dalbavancin to standard antibiotic treatment for patients with periprosthetic joint infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark